17 results on '"Mobile tongue"'
Search Results
2. Combined loss of expression of involucrin and cytokeratin 13 is associated with poor prognosis in squamous cell carcinoma of mobile tongue.
- Author
-
Pandey, Sushma, Søland, Tine Merete, Bjerkli, Inger Heidi, Sand, Lars Peter, Petersen, Fernanda Cristina, Costea, Daniela Elena, Senguven, Burcu, and Sapkota, Dipak
- Subjects
SQUAMOUS cell carcinoma ,TONGUE cancer ,KERATIN ,PROGNOSIS ,OVERALL survival ,TRANSCRIPTOMES - Abstract
Background: This study aimed to evaluate the prognostic significance of expression levels of involucrin (IVL), cytokeratin (CK)‐10 and ‐13 at different intratumor sites (tumor center and invading area) of oral tongue squamous cell carcinoma (OTSCC). Methods: IVL, CK13 and CK10 expression levels were examined in a multicenter cohort of 146 OTSCCs using immunohistochemistry. External mRNA datasets were used for expression analysis and/or to validate survival associations. Results: External transcriptomic datasets showed downregulation of IVL and KRT13 in oral malignancies including OTSCC as compared to normal controls. The combined loss of IVL and CK13 expression at the invading core but not at the center core was significantly associated with poor differentiation and reduced 5‐year overall survival. Multivariate Cox analysis confirmed the loss of CK13 and IVL expression to be an independent prognostic factor. Transcriptomic dataset corroborated immunohistochemistry results. Conclusions: Combined expression levlels of IVL and CK13 might be useful as prognostic biomarkers in OTSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Keratin 36, a specific marker of tongue filiform papillae, is downregulated in squamous cell carcinoma of the mobile tongue.
- Author
-
Brychtova, Veronika, Coates, Philip J., Hrabal, Vaclav, Boldrup, Linda, Fabian, Pavel, Vojtesek, Borivoj, Sgaramella, Nicola, and Nylander, Karin
- Subjects
- *
SQUAMOUS cell carcinoma , *KERATIN , *BASAL cell carcinoma , *TONGUE cancer , *CERVICAL cancer - Abstract
Human keratin 36 (K36) is a member of the hair keratin family and is a marker of hair cortex differentiation. The human KRT36 gene is located on the long arm of chromosome 17 and belongs to the cluster of structurally unrelated acidic hair keratins. Recently, it has been reported that KRT36 mRNA is specifically expressed in normal tongue epithelium and downregulated in squamous cell carcinomas of the mobile tongue. Furthermore, KRT36 levels have been reported to be downregulated in clinically normal mobile tongue tissue that is adjacent to tumours, suggesting it could be a marker of pre-neoplastic changes. However, the exact role and the potential role of K36 in tongue tumour formation remains unclear. The aim of the present study was to investigate expression of K36 in a series of squamous cell carcinomas of the mobile tongue, normal mobile tongue and a small panel of other human tissues (normal tissue from the appendix, cervix, hair, lip, mamilla, nail, oesophagus, skin, thymus and vagina) and selected cancer tissue (cervical cancer, melanoma and basal cell carcinoma). Affinity purified polyclonal antibodies against K36 were generated and used for immunohistochemical analysis. The results revealed that in the normal tongue, K36 was detected specifically in the filiform papillae of the dorsal surface of the tongue. Additionally, none of the tongue cancer tissue samples were K36-positive. Immunostaining also revealed that K36 was expressed in nail beds, Hassal's corpuscles in the thymus and the hair cortex. However, K36 was not expressed in the squamous epithelia of the skin, cervix and oesophagus, and the squamous cells of cervical carcinomas, basal cell carcinoma or melanoma. The present data indicated that K36 may be inactivated in tumours of the tongue. However, whether this is part of the tumoural process or if it is an effect of the tumour itself remains to be elucidated. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. A rapidly growing human papillomavirus-positive oral tongue squamous cell carcinoma in a 21-year old female: A case report.
- Author
-
Appah, Ebenezer O., Ballard, Billy Ray, Izban, Michael G., Jolin, Cassandra, Lammers, Philip E., Parrish Jr, Dwight D., and Marshall, Dana R.
- Subjects
- *
TONGUE cancer , *SQUAMOUS cell carcinoma , *PAPILLOMAVIRUS diseases , *POLYMERASE chain reaction , *GENETIC mutation - Abstract
Oral tongue squamous cell carcinoma (OTSCC) has a median age at diagnosis of 62 years. The incidence of OTSCC in young adults has been increasing, and the reason is unclear. The present study describes a case, and molecular analysis, of OTSCC in a 21-year-old female. Clinical and pathological information were collected from medical records. Formalin-fixed paraffin-embedded biopsy tissue from the patient was reassessed using standard hematoxylin & eosin staining, and immunohistochemistry was used to assess the expression of cellular p16, MutL homolog (MLH)1, MLH2, MutS homolog 6 (MSH6) and PMS1 homolog 2 (PMS2). The human papilloma virus (HPV) genome was detected by PCR analysis of the extracted DNA. The young age of the patient with OTSCC was unusual. The original pathology report indicated koilocytotic atypia, a cellular abnormality associated with HPV. Although HPV-positive oral cancer tends to occur in 'younger' individuals, 21 years is unusual. The confirmation of biologically active HPV in the tumor was obtained via the observation of strong positive staining for cellular p16. The patient described a maternal family cluster of rare cancer types, thus the possibility that this rapidly growing cancer resulted from HPV infection combined with an underlying genetic mutation causing decreased DNA-mismatch repair was explored. However, MSH1, MSH2, MSH6 and PSM2, proteins that are associated with Lynch Syndrome, were expressed at normal levels. A rapidly growing OTSCC of a 21-year-old female was determined to be HPV-positive. The patient underwent combination chemotherapy and radiation and has experienced long-term survival without recurrence. The reason this tumor grew so quickly in such a young individual remains unknown. These types of cases warrant additional genomic and proteomic studies to improve understanding of this phenomenon. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
5. Update from the 4th Edition of the World Health Organization of Head and Neck Tumours: Tumours of the Oral Cavity and Mobile Tongue.
- Author
-
Müller, Susan
- Abstract
There have been several additions and deletions in Chapter 4 on Tumours of the oral cavity and mobile tongue in the 2017 fourth edition of the World Health Organization Classification of Tumours of the Head and Neck. This chapter excludes the oropharynx, which now is a stand-alone chapter acknowledging the uniqueness of the oropharynx from the oral cavity. New entries in Chapter 4 include rhabdomyoma, haemangioma, schwannoma, neurofibroma and myofibroblastic sarcoma in the section titled Soft tissue and neural tumours. Discussion of salivary gland entities have been reduced and includes mucoepidermoid carcinoma and pleomorphic adenoma as the other salivary gland types are discussed elsewhere. In the Haematolymphoid tumours section, like the salivary gland section, only tumors that commonly present in the oral cavity are discussed in Chapter 4. Excluded entities in the updated classification include papillary hyperplasia, median rhomboid glossitis, keratoacanthoma, focal oral mucinosis, and secondary tumors. This article will summarize the changes in the new classification since the 2005 edition focusing on selected entities that have had significant changes along with new entries. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancer
- Author
-
Hideya Yamazaki, T. Shimbo, Mio Nakata, Yasuo Uesugi, Yutaka Tsujimoto, Nikolaos Tselis, Ken Yoshida, Hiroto Yoshioka, Tadayuki Kotsuma, Hironori Akiyama, Koji Masui, Tadashi Takenaka, Takumi Arika, Eiichi Tanaka, N. Yoshikawa, Yuji Takaoka, and Naoya Murakami
- Subjects
silicone device ,medicine.medical_treatment ,Brachytherapy ,lcsh:Medicine ,Case Report ,tongue edema ,chemistry.chemical_compound ,Silicone ,Tongue ,Edema ,medicine ,Dosimetry ,Radiology, Nuclear Medicine and imaging ,ddc:610 ,business.industry ,Interstitial brachytherapy ,lcsh:R ,Cancer ,medicine.disease ,medicine.anatomical_structure ,Oncology ,chemistry ,mobile tongue cancer ,medicine.symptom ,high-dose-rate interstitial brachytherapy ,Nuclear medicine ,business ,Mobile tongue - Abstract
Purpose: Tongue edema is a potential cause of treatment target underdosage in high-dose-rate interstitial brachytherapy (HDR-ISBT) of mobile tongue cancer. To prevent such edema-associated alteration of dosimetry, we developed a special silicon device. In this report we communicate our initial experience with two mobile tongue cancer patients whom we treated using this new device. Material and methods: The device consists of silicone tubes with a fixed width and scalable length depending on tongue size. These tubes are lined and fixed like a palisade, allowing the device to be used also as a template. The device is placed next to the lateral border of the tongue and on the floor of the mouth. In addition, a vinyl template can be placed on the dorsal tongue surface with both devices combined for implantation guidance. Between June and August 2012, two patients with locally confined tongue cancer were treated. Results: Between June and August 2012, two mobile tongue cancer patients classified as cT2N0M0 were treated with HDR-ISBT using the silicone device. They underwent ISBT as monotherapy with fractional doses of 6.0 Gy up to a total physical dose of 54.0 Gy. The D90 (CTV) values of both patients were 6.3 Gy and 6.6 Gy and the D2cc (mandible) values were 3.4 Gy and 2.6 Gy, respectively. At present, both patients remain without local disease recurrence at 60 and 56 months after ISBT, respectively. Conclusions: The described silicone device has the potential to prevent underdosage to the treatment target related to tongue edema. It has been shown to be safe and easy to implement.
- Published
- 2019
7. Long-term subjective tongue function after partial glossectomy.
- Author
-
Lee, D. Y., Ryu, Y.‐J., Hah, J. H., Kwon, T.‐K., Sung, M.‐W., and Kim, K. H.
- Subjects
- *
DEGLUTITION disorders , *TONGUE physiology , *ACADEMIC medical centers , *MULTIVARIATE analysis , *QUESTIONNAIRES , *SURGICAL complications , *DATA analysis software , *DESCRIPTIVE statistics , *DISEASE risk factors ,TONGUE surgery ,TONGUE tumors - Abstract
There have been limited studies of subjective tongue function over long-term follow-up in spite of swallowing and articulation disorders are common complications of glossectomy. To assess long-term subjective swallowing and articulation function after partial glossectomy. A total of 63 patients with the mobile tongue cancer who underwent partial glossectomy without reconstruction were interviewed to score their swallowing and articulation function on a 100-point scale. The relation of this subjective scoring to the perioperative data was subjected to multivariate analysis. The mean patient age was 53·4 (19-81) years, and the mean follow-up duration was 78·9 (14-277) months. Mean swallowing and articulation function score was 87·7 ± 6·1 and 88·6 ± 5·4. Age, follow-up duration, T stage and resection volume were significantly correlated with swallowing function ( P = 0·026, 0·029, 0·016, 0·002, respectively); follow-up duration was correlated with articulation function ( P = 0·039). Patients who undergo partial glossectomy without reconstruction generally demonstrate good function on long-term follow-up. Subjective dysfunction was correlated with larger resection volume, older age and shorter follow-up duration. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
8. Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
- Author
-
Theocharis, Stamatios, Klijanienko, Jerzy, Giaginis, Constantinos, Rodriguez, Jose, Jouffroy, Thomas, Girod, Angelique, Point, Daniel, Tsourouflis, Gerasimos, and Satre-Garau, Xavier
- Subjects
- *
SQUAMOUS cell carcinoma , *CANCER patients , *CANCER chemoprevention , *CANCER prognosis , *CLINICAL pathology , *IMMUNOHISTOCHEMISTRY , *PEROXISOMES , *GENE expression , *TONGUE cancer , *CANCER treatment - Abstract
Purpose: Peroxisome proliferator-activated receptor-γ (PPAR-γ) is a ligand-activated transcription factor, implicated in various aspects of cancer biology, such as differentiation, proliferation, invasion and angiogenesis. The present study aimed to evaluate the clinical significance of PPAR-γ in mobile tongue squamous cell carcinoma (SCC). Methods: PPAR-γ protein expression was assessed immunohistochemically on 49 mobile tongue SCC tissue samples obtained from an equal number of patients. PPAR-γ expression and intensity of immunostaining were statistically analyzed in relation with clinicopathological characteristics, mitotic index and patients' survival. Results: Elevated PPAR-γ expression was more frequently observed in patients with reduced depth of invasion ( P = 0.0111). Moderate/intense PPAR-γ staining intensity was more frequently observed in patients with no evidence of muscular infiltration ( P = 0.0229) and reduced depth of invasion ( P = 0.0176). Mobile tongue SCC patients presenting enhanced PPAR-γ expression had significantly longer overall and disease-free survival times compared to those with low PPAR-γ expression (log-rank test, P = 0.0162 and P = 0.0114, respectively). Conclusions: PPAR-γ immunoreactivity in mobile tongue SCC was correlated with clinicopathological characteristics crucial for patients' management and prognosis. PPAR-γ may be considered as a useful prognostic marker in mobile tongue SCC and a potential therapeutic target for tongue cancer chemoprevention and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
9. Keratin 36, a specific marker of tongue filiform papillae, is downregulated in squamous cell carcinoma of the mobile tongue
- Author
-
Nicola Sgaramella, Philip J. Coates, Veronika Brychtová, Pavel Fabian, Linda Boldrup, Karin Nylander, Václav Hrabal, and Borivoj Vojtesek
- Subjects
keratin 36 ,squamous cell carcinoma ,Cancer Research ,Pathology ,medicine.medical_specialty ,Biology ,Hair keratin ,03 medical and health sciences ,0302 clinical medicine ,Tongue ,thymus ,Keratin ,medicine ,Basal cell carcinoma ,nail ,chemistry.chemical_classification ,mobile tongue ,Cancer och onkologi ,integumentary system ,Cancer ,Articles ,medicine.disease ,Epithelium ,medicine.anatomical_structure ,Oncology ,chemistry ,030220 oncology & carcinogenesis ,Cancer and Oncology ,Immunohistochemistry ,030211 gastroenterology & hepatology ,Immunostaining - Abstract
Human keratin 36 (K36) is a member of the hair keratin family and is a marker of hair cortex differentiation. The human KRT36 gene is located on the long arm of chromosome 17 and belongs to the cluster of structurally unrelated acidic hair keratins. Recently, it has been reported that KRT36 mRNA is specifically expressed in normal tongue epithelium and downregulated in squamous cell carcinomas of the mobile tongue. Furthermore, KRT36 levels have been reported to be downregulated in clinically normal mobile tongue tissue that is adjacent to tumours, suggesting it could be a marker of pre-neoplastic changes. However, the exact role and the potential role of K36 in tongue tumour formation remains unclear. The aim of the present study was to investigate expression of K36 in a series of squamous cell carcinomas of the mobile tongue, normal mobile tongue and a small panel of other human tissues (normal tissue from the appendix, cervix, hair, lip, mamilla, nail, oesophagus, skin, thymus and vagina) and selected cancer tissue (cervical cancer, melanoma and basal cell carcinoma). Affinity purified polyclonal antibodies against K36 were generated and used for immunohistochemical analysis. The results revealed that in the normal tongue, K36 was detected specifically in the filiform papillae of the dorsal surface of the tongue. Additionally, none of the tongue cancer tissue samples were K36-positive. Immunostaining also revealed that K36 was expressed in nail beds, Hassal's corpuscles in the thymus and the hair cortex. However, K36 was not expressed in the squamous epithelia of the skin, cervix and oesophagus, and the squamous cells of cervical carcinomas, basal cell carcinoma or melanoma. The present data indicated that K36 may be inactivated in tumours of the tongue. However, whether this is part of the tumoural process or if it is an effect of the tumour itself remains to be elucidated.
- Published
- 2020
10. Neodymium YAG Contact Laser in the Treatment of Cancer of the Mobile Tongue.
- Author
-
Luukkaa, Marjaana, Aitasalo, Kalle, Pulkkinen, Jaakko, Lindholm, Paula, Valavaara, Ritva, and Grénman, Reidar
- Subjects
- *
ND-YAG lasers , *TONGUE cancer , *CANCER treatment , *THERAPEUTICS - Abstract
The aim of this study was to evaluate the usefulness of a contact neodymium YAG laser for the treatment of squamous cell carcinoma (SCC) of the mobile tongue in 35 patients. The TNM stage and histologic grade were as follows: T1, n = 20; T2, n = 11; T3, n = 4; and N0, n = 33; N1, n = 2; G1, n = 20; G2, n = 10; and G3, n = 5. The surgical treatment consisted of a hemiglossectomy or resection with adequate margins in 28 cases, and an ipsilateral neck dissection was also performed in 7 patients. Radiotherapy to a mean tumor dose of 62-64 Gy and an elective dose of 50 Gy to the cervical lymph nodes was given to 14 patients. The radiotherapy was preoperative in 12 patients and postoperative in 2. Tongue resection was easily performed using the contact neodymium YAG laser, with a mean operation time of 31 min and intraoperative bleeding varying from negligible to 100 cm[sup 3]. During postoperative follow-up no major complications occurred: cases with minor hemorrhage were easily controlled on the ward and 1 patient had a bleed on the 14th postoperative day necessitating hospitalization. The resection was histologically radical in all cases. During follow-up one patient had a local recurrence (T2N0, G3) and four failed in the neck (T1N0 G2, T1N0 G2, T1N0 G2, T2N0 G2), three of whom were successfully salvaged with a neck dissection and radiotherapy. One patient with osteoradionecrosis was diagnosed and treated curatively. Two patients died of their tongue cancer (T2N0 G3, T2N0 G2), 1 died from a second primary tumor (T2N0 G1) and 2 of intercurrent disease with no evidence of cancer; 30 patients (86%) are still alive with no evidence of disease. The function of the tongue in all patients in this sample was good to satisfactory. The major complaint was xerostomia in the irradiated patients. In conclusion, the contact neodymium YAG laser appears to be suitable for resection of T1-T2 SCCs of the oral tongue. In this limited patient sample T stage or grade did not predict failures in the neck. Biologic predictive markers need to be evaluated. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
11. Edema worsens target coverage in high-dose-rate interstitial brachytherapy of mobile tongue cancer: a report of two cases
- Author
-
T. Shimbo, N. Yoshikawa, Yoshifumi Narumi, Eiichi Tanaka, Takumi Arika, Tadayuki Kotsuma, Hironori Akiyama, Yasuo Uesugi, Hiroto Yoshioka, Ken Yoshida, Koji Masui, Hideya Yamazaki, Yasuo Yoshioka, and Tadashi Takenaka
- Subjects
0106 biological sciences ,medicine.medical_specialty ,medicine.medical_treatment ,Brachytherapy ,lcsh:Medicine ,Case Report ,HDR ,01 natural sciences ,03 medical and health sciences ,0302 clinical medicine ,Tongue ,Edema ,Medicine ,Radiology, Nuclear Medicine and imaging ,business.industry ,Interstitial brachytherapy ,lcsh:R ,tongue cancer ,Cancer ,medicine.disease ,Surgery ,Splints ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Radiology ,medicine.symptom ,business ,Dose rate ,Mobile tongue ,edema ,target coverage ,010606 plant biology & botany - Abstract
Purpose : We report our study on two patients to highlight the risk of underdosage of the clinical target volume (CTV) due to edema during high-dose-rate interstitial brachytherapy (HDR-ISBT) of mobile tongue cancer. Material and methods : To treat the lateral side of the CTV, flexible applicator tubes were implanted on the mouth floor. Two-dimensional planning was performed using X-ray images for Case 1, and three-dimensional (3D) planning was performed using computed tomography (CT) for Case 2. Prescribed doses for both cases were 54 Gy in nine fractions. Case reports : Case 1 was treated for cancer of the right lateral border of the tongue in 2005. Tongue edema occurred after implantation, and part of the lateral border of the tongue protruded between the applicator tubes. Acute mucosal reaction abated in the protruded area earlier than in the other parts of the CTV. In this case, the tumor recurred in this area 5 months after the treatment. Case 2 was treated for cancer of the left lateral border of the tongue. Because tongue edema occurred in this case also, plastic splints were inserted between the applicator tubes to push the edematous region into the irradiated area. The mucosal surface of the CTV was covered by the 70% isodose, and 100% isodose line for before and after splint insertion. Local control of the tumor was achieved 4 years after treatment. Discussion and conclusions : To ensure sufficient target coverage, 3D image-based planning using CT should be performed, followed by re-planning using repeated CT as needed. Also, the development of devices to prevent protrusion of the edematous tissue outside the target area will help to ensure the full dosing of CTV.
- Published
- 2017
12. High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial
- Author
-
Kimishige Shimizutani, Ken Yoshida, Takumi Arika, Hideya Yamazaki, Eiichi Tanaka, Koji Masui, Yasuo Yoshioka, Tadayuki Kotsuma, Hironori Akiyama, and Tadashi Takenaka
- Subjects
medicine.medical_specialty ,Original Paper ,business.industry ,medicine.medical_treatment ,Interstitial brachytherapy ,Brachytherapy ,tongue cancer ,Cancer ,medicine.disease ,High-Dose Rate Brachytherapy ,Surgery ,Oncology ,dose reduction ,high-dose-rate brachytherapy ,medicine ,Radiology, Nuclear Medicine and imaging ,Dose reduction ,Adverse effect ,business ,Nuclear medicine ,Survival rate ,Mobile tongue - Abstract
Purpose: To compare the outcome of our facility with another about the shortened schedule (60 Gy in 10 fractions to 54 Gy in 9 fractions) of high-dose-rate interstitial brachytherapy (HDR ISBT) for mobile tongue cancer. Material and methods: Eighteen patients were treated with HDR ISBT as a monotherapy in dose reduction schedule with some unique technique to determine the border of tumor accuracy (lugol’s staining and metal marker), and to minimize adverse effect (lead-lined silicon block) at our facility. Results: The 2-year local and regional control rates and cause-specific survival rate were 82%, 80%, and 83% and moderate to severe late complications occurred in five patients (28%), which were almost the same treatment results achieved by another facility. Conclusions: We recommend 54 Gy in 9 fractions over 7 days as a feasible treatment to reduce patient discomfort in mobile tongue cancer patients. J Contemp Brachytherapy 2014; 6, 1: 10–14 DOI: 10.5114/jcb.2014.40726
- Published
- 2014
13. A fish bone embedded in the mobile tongue mimicking a neoplasm.
- Author
-
Wang, Yan and Li, Wen
- Subjects
CASE studies ,TONGUE surgery ,TONGUE diseases ,FOREIGN bodies ,BIOPSY ,TUMORS ,LARYNGOSCOPY ,ENDOSCOPY ,PHARYNGEAL bursa ,GRANULOMA ,DIAGNOSIS - Abstract
Foreign bodies embedded in a mobile tongue as an enlarged tongue mass are rarely presented to either a laryngologist or a dentist, because such bodies are commonly lodged superficially and are easily removed by the patients themselves or removed by a laryngologist by means of indirect laryngoscope or endoscope. We have described a 63-year-old female with an 8-month history of an enlarged mass in the anterior right tongue. Physical examination demonstrated a mass located in the anterior right tongue without clear margin, with superficially intact mucosa and normal colour. A benign tongue neoplasm was first considered. However, a fish bone totally embedded in the mobile tongue with granuloma formation was encountered during the incisional biopsy operation. Complete removal of the foreign body with granuloma was achieved under general anaesthesia. There was no neuromuscular or neurosensory dysfunction of the tongue in the follow-up period of 2 years. Although an embedded foreign body in the mobile tongue is a rare condition, it should be considered in the work-up of a patient with an enlarged tongue mass, with or without a history of swallowing a foreign body. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
14. A foreign body embedded in the mobile tongue masquerading as a neoplasm.
- Author
-
Chao-Jung Lin, Wan-Fu Su, and Chih-Hung Wang
- Subjects
- *
TONGUE cancer , *TUMORS , *GRANULOMA , *BIOPSY , *CLINICAL pathology , *LOCAL anesthesia , *OTOLARYNGOLOGY - Abstract
Foreign bodies in a mobile tongue are rarely presented to the laryngologist, because such bodies are commonly lodged superficially and are easily removed by the patients themselves or by general practitioners. Thus, it is rare that a foreign body totally embedded in the mobile part of the tongue presents as an enlarged tongue mass. We have described a 64-year-old female with a 3-month history of an enlarged mass in the anterior right tongue. Physical examination showed a mass located in the anterior right tongue, with intact mucosa and normal color. A benign tongue neoplasm was considered first. However, a fish bone totally embedded in the mobile tongue with granuloma formation was encountered during the incisoinal biopsy operation. Complete removal of the foreign body with granuloma was achieved under local anesthesia. There was no neuromuscular or neurosensory deficit of the tongue in the follow-up period of 2 years. Although an embedded foreign body in the mobile tongue is a rare condition, it should be considered in the work-up of a patient with an enlarged tongue mass, with or without a history of swallowing a foreign body. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
15. Visualization of the sentinel node in early-stage oral cancer: limited value of late static lymphoscintigraphy
- Author
-
S. van Weert, C.R. Leemans, Elisabeth Bloemena, Derrek A. Heuveling, R. de Bree, K.H. Karagozoglu, Géke B. Flach, A. van Schie, MKA Vumc (OII, ACTA), Maxillofacial Surgery (VUmc), Otolaryngology / Head & Neck Surgery, Radiology and nuclear medicine, Oral and Maxillofacial Surgery / Oral Pathology, Pathology, and CCA - Innovative therapy
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pathology ,Oral cavity ,Injections ,Text mining ,SDG 3 - Good Health and Well-being ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Clinical significance ,Aged ,Neoplasm Staging ,Retrospective Studies ,Aged, 80 and over ,business.industry ,General Medicine ,Middle Aged ,Sentinel node ,Lymphatic Metastasis ,Clinical value ,Female ,Mouth Neoplasms ,Radiology ,business ,Mobile tongue ,Lymphoscintigraphy - Abstract
Objective: Various lymphoscintigraphic imaging protocols exist for sentinel node (SN) identification in early-stage oral cancer. This study aimed to evaluate the clinical value of performing additional late lymphoscintigraphic imaging. Methods: We retrospectively analysed early (directly following injection of 99mTc-Nanocoll) and late (2-4 h after injection) imaging results of 60 early-stage (T1-T2, cN0) oral cancer patients scheduled for SN procedure. Lymphoscintigraphic results of late imaging were categorized into: (a) no visualization of additional hotspots considered to be SNs; (b) additional hotspots visualized that are considered to be SNs and (c) hotspots visualized only during late imaging. Histopathological results of the harvested SNs were related to the corresponding hotspot. Results: In all patients (n=60) lymphoscintigraphy was able to visualize a hotspot that was identified as an SN. In 51/60 (85%) patients, early imaging was able to visualize at least one hotspot, whereas in 9/60 (15%) patients, mostly with oral cavity tumours other than mobile tongue and floor-of-mouth tumours, only late imaging was able to visualize hotspots. In 14/51 (27%) patients, late imaging resulted in additionally visualized hotspots marked as SNs, resulting in a more extensive surgical procedure. These additionally removed SNs appeared to be of no clinical relevance, as all SNs identified during early imaging correctly predicted whether the neck was positive or negative for cancer.Conclusion: Results of this study indicate that additional late lymphoscintigraphic imaging should be performed only in selected cases.
- Published
- 2012
- Full Text
- View/download PDF
16. Autologous embedded foreign body of mobile tongue.
- Author
-
Verma, Rohit, Sikka, Kapil, and Thakar, A.
- Subjects
- *
FOREIGN bodies , *ALIMENTARY canal , *OTOLARYNGOLOGY , *RARE diseases , *SURGERY - Abstract
Foreign bodies of upper aerodigestive tract are common otorhinolarygological emergencies. The foreign bodies of mobile tongue are however very rare and there are only limited case reports in literature. The case of a young female with an autologous foreign body mobile tongue with unusual presentation is presented. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
17. Application of ultrasonic probe with a needle for surveying a fish bone embedded in the tongue
- Author
-
Tokutaro Minamizato, Yoshinori Sumita, Mayumi Umebayashi, and Izumi Asahina
- Subjects
medicine.diagnostic_test ,business.industry ,Computed tomography ,Anatomy ,medicine.anatomical_structure ,Tongue ,Emergency Medicine ,medicine ,Ultrasonic sensor ,Surgery ,Orthopedics and Sports Medicine ,business ,Mobile tongue ,Foreign Bodies ,Biomedical engineering ,Fish bone - Abstract
Detection and localization of foreign bodies within soft tissue is often difficult, particularly those in the mobile tongue. However, few reports have related definitive procedures for the removal of foreign bodies in the tongue. Computed tomography (CT) is usually utilized to detect foreign bodies, but cannot provide real-time information during removal operations. We report a case involving a fishbone embedded in the mobile tongue that was easily retrieved using ultrasonic probing with a 26-G needle as a landmark.
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.